MyAverix Finance
F · Healthcare
PROBIOTIX HEALTH LS-05 (X90)
Biotechnology
PROBIOTIX HEALTH LS-05 (X90) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-21, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for X90
PROBIOTIX HEALTH LS-05 (X90) — FAQ
What is X90's P/E ratio?
The price-to-earnings (P/E) ratio for PROBIOTIX HEALTH LS-05 (X90) is 25.00 (data as of 2026-05-21).
Does PROBIOTIX HEALTH LS-05 pay a dividend?
Dividend yield is not available in the current snapshot for PROBIOTIX HEALTH LS-05 (X90). Check the MyAverix Finance app for the latest dividend data.
What sector is PROBIOTIX HEALTH LS-05 in?
PROBIOTIX HEALTH LS-05 (X90) is classified in the Healthcare sector (Biotechnology industry).
What exchange is X90 listed on?
X90 is listed on F.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.